Although long-term MRI follow-up was beyond the scope of this study, existing literature highlights a high recurrence rate in gliomas, PPTID, and particularly PTPR–where recurrence may reach up to 80% despite GTR.7,17 postoperative complications such as visual deficits, hemiparesis, and memory issues have been reported but are often transient and rarely life-threatening.15,19 Hormone replacement therapy is seldom necessary unless hypothalamic involvement is present, which remains uncommon across most series. The gene discussed is PTPRR; the disease is glioma.